Hospital Luis Calvo Mackenna Researchers Illuminate Research in Tacrolimus Therapy [Evaluation of limited-sampling strategies to calculate AUC(0-24) and the role of CYP3A5 in Chilean pediatric kidney recipients using extended-release tacrolimus].

Předmět:	TACROLIMUS CYTOCHROME P-450 CYP3A KIDNEYS IMMUNOSUPPRESSIVE agents DRUG therapy
Zdroj:	Drug Week; 3/31/2023, p811-811, 1p
Abstrakt:	Keywords: Drugs and Therapies; Health and Medicine; Immunosuppressive Agents; Macrolides; Pediatrics; Pharmaceuticals; Tacrolimus; Tacrolimus Therapy EN Drugs and Therapies Health and Medicine Immunosuppressive Agents Macrolides Pediatrics Pharmaceuticals Tacrolimus Tacrolimus Therapy 811 811 1 03/27/23 20230331 NES 230331 2023 MAR 31 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators discuss new findings in tacrolimus therapy. Daily TAC dose (TAC-D mg/kg) and AUC(0-24) normalized by dose were compared between CYP3A5 expressors (1/1 and 1/3) and non-expressors (3/3). [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu